Tatiana V. Umpeleva - Infectious Diseases

Author Information

Tatiana V. Umpeleva is affiliated with the National Medical Research Center for Phthisiopulmonology and Infectious Diseases, located in Yekaterinburg, Russia. Her research primarily focuses on the study of Mycobacterium tuberculosis, which is crucial for understanding and controlling tuberculosis, a significant public health challenge.

Research Contributions

Tatiana Umpeleva has made substantial contributions to the field of infectious diseases, with a particular emphasis on tuberculosis and its resistance to drugs. Her research includes the molecular characterization of drug-resistant Mycobacterium tuberculosis, the development of methods for drug susceptibility testing, and the exploration of biobanks to support research in phthisiology and infectious diseases. She has also investigated the prevalence of epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions and the socio-medical aspects of resistance development to new anti-TB drugs. Her work is important for the detection and surveillance of emerging highly resistant strains, as well as for understanding the interaction between tuberculosis bacteria and host immune responses in pulmonary tuberculosis.

Aliases

Tatiana V. Umpeleva is also known by several aliases, including T. V. Umpeleva, Tatiana Umpeleva, T V Umpeleva, and Tatiana V Umpeleva.

Publication and Citation Metrics

Metric	Value
Citation Count	97
H-index	6
Paper Count	21

Publications:

Molecular Characteristics of Mycobacterium Tuberculosis Drug-Resistant Isolates from HIV- and HIV+ Tuberculosis Patients in Russia

DOI: 10.21203/rs.3.rs-1159825/v1

Year: 2022

Comparison of Different Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis to Rifampicin

DOI: 10.21292/2075-1230-2022-100-1-41-48

Year: 2022

Biobank as a key component of supporting research in phthisiology and infectious diseases

DOI: 10.15829/1728-8800-2021-3084

Year: 2022

Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster

DOI: 10.1038/s41598-021-00890-7

Year: 2021

Mycobacterium tuberculosis Load in Host Cells and the Antibacterial Activity of Alveolar Macrophages Are Linked and Differentially Regulated in Various Lung Lesions of Patients with Pulmonary Tuberculosis

DOI: 10.3390/ijms22073452

Year: 2021

Prevalence of the epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions

DOI: 10.1183/13993003.congress-2021.pa1723

Year: 2021

Development of technology for longterm storage of Mycobacterium tuberculosis cultures

DOI: 10.36488/cmac.2021.4.404-408

Year: 2021

Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB

DOI: 10.1183/13993003.congress-2021.pa3339

Year: 2021

Molecular characteristics of Mycobacterium tuberculosis in the "closed" Russian town with limited population migration.

DOI: 10.1016/j.meegid.2020.104174

Year: 2020

Analysis of Mycobacterium tuberculosis Uptake by Alveolar Macrophages after Ex vivo Expansion Indicates Processing Host Cells with Pathogen Actually from Lung Tissue of Patients with Pulmonary Tuberculosis

DOI: 10.4103/ijmy.ijmy_39_20

Year: 2020

How Do Insect Repellents Work?

What Diseases are Transmitted by Culex Mosquitoes?

Are There Any Emerging Technologies in Mosquito Control?

What Role Do Sporozoites Play in the Disease Cycle?

What is the Future of the Global Fund?

When Should Masks Be Worn?

How Can Adverse Effects be Minimized?

What are the Symptoms of E. Coli Infection?

What Should You Discuss with Your Healthcare Provider?

What are Common Methods for Symptomatic Relief?

Partnered Content Networks

Relevant Topics